Levacin 100/25

Levacin 100/25 is a medicine authorised by Swissmedic under authorisation number 57674. The authorisation holder is Acino Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 May 2009 and the authorisation is valid without a time limit. ATC code N04BA02 places the medicine in the group Anti-Parkinson drugs.

  • Dispensing category B
  • Authorisation number 57674
  • ATC N04BA02
  • Synthetic medicines
Authorisation data
Authorisation number57674
NameLevacin 100/25
Full nameLevacin 100/25, Retardtabletten
Authorisation holderAcino Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN04BA02
First authorisation28 May 2009
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Levacin 100/25, RetardtablettenB28 May 2009
2Levacin 200/50, RetardtablettenB28 May 2009

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1330Tablette(n)N04BA0201.08.0.B
14100Tablette(n)N04BA0201.08.0.B
1530Tablette(n)N04BA0201.08.0.B
16100Tablette(n)N04BA0201.08.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Levacin 100/25 authorised in Switzerland?

Yes. Levacin 100/25 is authorised by Swissmedic under authorisation number 57674, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Levacin 100/25 have?

Levacin 100/25 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Levacin 100/25?

The authorisation holder is Acino Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com